Shrinkage of olfactory amygdala connotes cognitive impairment in patients with Parkinson's disease.
Parkinson’s disease
amygdala
cognition
hyposmia
magnetic resonance imaging
olfactory amygdala
Journal
Cognitive neurodynamics
ISSN: 1871-4080
Titre abrégé: Cogn Neurodyn
Pays: Netherlands
ID NLM: 101306907
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
15
12
2021
revised:
04
09
2022
accepted:
14
09
2022
pmc-release:
01
10
2024
medline:
3
10
2023
pubmed:
3
10
2023
entrez:
3
10
2023
Statut:
ppublish
Résumé
During the caudo-rostral progression of Lewy pathology, the amygdala is involved relatively early in Parkinson's disease (PD). However, lesser is known about the volumetric differences at the amygdala subdivisions, although the evidence mainly implicates the olfactory amygdala. We aimed to investigate the volumetric differences between the amygdala's nuclear and sectoral subdivisions in the PD cognitive impairment continuum compared to healthy controls (HC). The volumes of nine nuclei of the amygdala were estimated with FreeSurfer (nuclear parcellation-NP) from T1-weighted images of PD patients with normal cognition (PD-CN), PD with mild cognitive impairment (PD-MCI), PD with dementia (PD-D), and HC. The appropriate nuclei were then merged to obtain three sectors of the amygdala (sectoral parcellation-SP). The nuclear and sectoral volumes were compared among the four groups and between the hyposmic and normosmic PD patients. There was a significant difference in the total amygdala volume among the four groups. In terms of nuclei, the bilateral cortico-amygdaloid transition area (CAT) and sectors superficial cortex-like region (sCLR) volumes of PD-MCI and PD-D were less than those of the PD-CN and HC. A linear discriminant analysis revealed that left CAT and left sCLR volumes classified the PD-CN and cognitively impaired PD (PD-CI: PD-MCI plus PD-D) with 90.7% accuracy according to NP and 85.2% accuracy to SP. Similarly, left CAT and sCLR volumes correctly identified the hyposmic and normosmic PD with 64.8% and 61.1% accuracies. Notably, the left olfactory amygdala volume successfully discriminated cognitive impairment in PD and could be used as neuroimaging-based support for PD-CI diagnosis. The online version contains supplementary material available at 10.1007/s11571-022-09887-y.
Identifiants
pubmed: 37786655
doi: 10.1007/s11571-022-09887-y
pii: 9887
pmc: PMC10542039
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1309-1320Informations de copyright
© The Author(s), under exclusive licence to Springer Nature B.V. 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Déclaration de conflit d'intérêts
Competing interestsThe authors report no competing interests.
Références
Brain. 2007 Jul;130(Pt 7):1787-98
pubmed: 17535834
Brain Pathol. 2010 May;20(3):633-9
pubmed: 20522088
Mov Disord. 2011 Aug 15;26(10):1814-24
pubmed: 21661055
Cell Tissue Res. 2004 Oct;318(1):121-34
pubmed: 15338272
J Neuropathol Exp Neurol. 2019 Oct 1;78(10):891-899
pubmed: 31504679
J Neurol Neurosurg Psychiatry. 2007 Mar;78(3):254-9
pubmed: 17028119
Front Syst Neurosci. 2013 Oct 10;7:66
pubmed: 24124415
Eur J Radiol. 2021 Nov;144:109985
pubmed: 34619619
J Neuropathol Exp Neurol. 2002 May;61(5):413-26
pubmed: 12030260
Neurology. 2009 Mar 31;72(13):1121-6
pubmed: 19020293
Mov Disord. 2007 Sep 15;22(12):1689-707; quiz 1837
pubmed: 17542011
Parkinsonism Relat Disord. 2015 Oct;21(10):1219-26
pubmed: 26321021
Neurology. 2015 Oct 13;85(15):1276-82
pubmed: 26362285
Neuropsychologia. 2010 Oct;48(12):3416-29
pubmed: 20619280
J Neurol. 2002 Oct;249 Suppl 3:III/1-5
pubmed: 12528692
Brain. 2012 Jan;135(Pt 1):161-9
pubmed: 22287381
Neurology. 2008 Mar 25;70(13):1017-22
pubmed: 18362281
Acta Neuropathol. 2008 Jul;116(1):125-8; author reply 129-31
pubmed: 18446352
Brain. 2010 Jun;133(Pt 6):1755-62
pubmed: 20371510
J Neural Transm (Vienna). 2020 Sep;127(9):1285-1294
pubmed: 32632889
J Neuropathol Exp Neurol. 2005 Jul;64(7):623-8
pubmed: 16042314
Front Neurol. 2019 Dec 18;10:1329
pubmed: 31920949
Anat Embryol (Berl). 2005 Dec;210(5-6):343-52
pubmed: 16208455
J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):188-94
pubmed: 21890574
Neuroimage. 2017 Jul 15;155:370-382
pubmed: 28479476
Neurology. 1997 Dec;49(6):1570-6
pubmed: 9409348
Proc Natl Acad Sci U S A. 1998 May 26;95(11):6469-73
pubmed: 9600990
Learn Mem. 2003 Sep-Oct;10(5):319-25
pubmed: 14557604
Ann N Y Acad Sci. 1999 Jun 29;877:397-411
pubmed: 10415661
Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
pubmed: 12498954
Mov Disord. 2012 Apr 15;27(5):597-607
pubmed: 22508278
J Neurol Neurosurg Psychiatry. 1997 May;62(5):436-46
pubmed: 9153598
Curr Opin Neurol. 2014 Aug;27(4):434-41
pubmed: 24978368
Eur J Neurol. 2018 Jan;25(1):148-153
pubmed: 28941002
J Neurol Neurosurg Psychiatry. 2016 May;87(5):493-500
pubmed: 25986365
Acta Neuropathol. 1999 Aug;98(2):157-64
pubmed: 10442555
Nat Rev Neurol. 2010 Jun;6(6):309-17
pubmed: 20479780
Hum Brain Mapp. 2017 Jul;38(7):3566-3578
pubmed: 28464508
Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):11050-5
pubmed: 10984517
J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
pubmed: 1564476
Parkinsonism Relat Disord. 2019 Jul;64:124-131
pubmed: 30948243
Acta Neuropathol. 1994;88(6):493-500
pubmed: 7879596
Neurosci Lett. 2009 Apr 3;453(2):77-80
pubmed: 19356597
Neuropathol Appl Neurobiol. 2007 Dec;33(6):599-614
pubmed: 17961138
J Neuropathol Exp Neurol. 2018 Jan 1;77(1):2-20
pubmed: 29186501
Brain. 2002 Nov;125(Pt 11):2431-45
pubmed: 12390970
Acta Neuropathol. 2008 Apr;115(4):399-407
pubmed: 18297293
Folia Neuropathol. 2004;42(3):141-50
pubmed: 15535032
Ann N Y Acad Sci. 2009 Jul;1170:615-22
pubmed: 19686202
Nature. 2015 Jan 15;517(7534):284-92
pubmed: 25592533
Arch Neurol. 2011 Dec;68(12):1562-8
pubmed: 22159053
Mov Disord. 2008 Oct 30;23(14):1984-90
pubmed: 18759360
Neuroimage. 2012 Apr 2;60(2):1226-35
pubmed: 22245260
Acta Neuropathol. 2009 Jun;117(6):613-34
pubmed: 19399512
Neuron. 2002 Jan 31;33(3):341-55
pubmed: 11832223
Neuroimage. 2011 Oct 1;58(3):741-8
pubmed: 21726652
Mov Disord. 2015 Feb;30(2):245-52
pubmed: 25600157
Neurobiol Aging. 2008 Jul;29(7):1027-39
pubmed: 17368653
Acta Neuropathol. 2008 Jul;116(1):1-16
pubmed: 18592254
Brain Pathol. 2008 Apr;18(2):220-4
pubmed: 18241240
Mov Disord. 2005 May;20(5):540-4
pubmed: 15645532
Ann Neurol. 1989 Sep;26(3):309-20
pubmed: 2802531
Mov Disord. 2012 Mar;27(3):349-56
pubmed: 22275317
Neuroimage. 2012 Aug 15;62(2):774-81
pubmed: 22248573